Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy-Reference-Cited by-同舟云学术

Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy

Published:2018-08-23 Issue:2 Volume:19 Page:381-390
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Pinelli David F.¹^ORCID,Zachary Andrea A.²,Friedewald John J.³^ORCID,Gjertson David W.⁴,Evans Michelle A.¹,Chatroop Erik N.¹,Leffell Mary S.²,Vo Ashley A.⁵,Jordan Stanley C.⁵,Montgomery Robert A.²,Tambur Anat R.¹

Affiliation:

1. Division of Transplant Surgery; Northwestern University Feinberg School of Medicine, Comprehensive Transplant Center; Chicago IL USA

2. Department of Medicine; Johns Hopkins University School of Medicine; Baltimore MD USA

3. Division of Nephrology and Hypertension, Department of Medicine; Northwestern University; Chicago IL USA

4. Division of Biostatistics; University of California; Los Angeles School of Public Health; Los Angeles CA USA

5. Cedars-Sinai Medical Center, Comprehensive Transplant Center; Los Angeles CA USA

Funder

The Paul I Terasaki Memorial Research Fund

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.15007/fullpdf

Reference36 articles.

1. Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts;Baldwin;Curr Opin Organ Transplant,2016

2. Utility of HLA antibody testing in kidney transplantation;Konvalinka;J Am Soc Nephrol,2015

3. Summary of FDA antibody-mediated rejection workshop;Archdeacon;Am J Transplant,2011

4. Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays;Visentin;Transplantation,2014

5. HLA diagnostics: Evaluating DSA strength by titration;Tambur;Transplantation,2018

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

2. A simple predictor for donor‐specific anti‐HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation;HLA;2024-08

3. Reduction of HLA donor specific antibodies in heart transplant patients treated with proteasome inhibitors for antibody mediated rejection;Clinical Transplantation;2023-09-13

4. Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines;Transplant International;2023-06-28

5. Defining the lower and upper limits of immunological risk of HLA antibody incompatible kidney transplantation: Current state of the art and limitations;Transplant Immunology;2023-02